AbbVie Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . AbbVie Inc
ABBV Stock  USD 213.85  0.62  0.29%   
AbbVie financial statements provide useful quarterly and yearly information to potential AbbVie Inc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on AbbVie financial statements helps investors assess AbbVie's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting AbbVie's valuation are summarized below:
Gross Profit
39.6 B
Profit Margin
0.0759
Market Capitalization
378.6 B
Enterprise Value Revenue
7.8142
Revenue
56.3 B
There are over one hundred nineteen available fundamental signals for AbbVie Inc, which can be analyzed over time and compared to other ratios. All traders should should validate AbbVie's prevailing fundamental trends against the trends from 2010 to 2025 to make sure the company is sustainable. Market Cap is likely to climb to about 296.4 B in 2025

AbbVie Total Revenue

35.6 Billion

Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.8 B, Interest Expense of 2.9 B or Selling General Administrative of 8.3 B, as well as many indicators such as Price To Sales Ratio of 3.46, Dividend Yield of 0.0288 or PTB Ratio of 99.06. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.
  
Check out the analysis of AbbVie Correlation against competitors.

AbbVie Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding1.8 B2 B1.7 B
Slightly volatile
Total Assets85.7 B135.2 B78.4 B
Slightly volatile
Other Current Liabilities30.4 B29 B13.5 B
Slightly volatile
Total Current Liabilities20.2 B38.7 B18.4 B
Slightly volatile
Other Liabilities38.3 B36.5 B17.9 B
Slightly volatile
Property Plant And Equipment Net3.7 B5.1 B3.4 B
Slightly volatile
Accounts Payable1.9 B2.9 B1.7 B
Slightly volatile
Cash10.2 B5.5 B9.4 B
Slightly volatile
Non Current Assets Total61.9 B109.6 B56.7 B
Slightly volatile
Other Assets5.8 B5.6 B2.6 B
Slightly volatile
Cash And Short Term Investments10.7 B5.6 B9.8 B
Slightly volatile
Net Receivables7.2 B10.9 B6.6 B
Slightly volatile
Good Will19.9 B35 B18.2 B
Slightly volatile
Liabilities And Stockholders Equity85.7 B135.2 B78.4 B
Slightly volatile
Non Current Liabilities Total58.6 B93 B53.6 B
Slightly volatile
Inventory2.3 B4.2 B2.1 B
Slightly volatile
Other Current Assets3.6 B4.9 B3.3 B
Slightly volatile
Total Liabilities78.8 B131.8 B72.1 B
Slightly volatile
Property Plant And Equipment Gross12.9 B12.3 B5.6 B
Slightly volatile
Total Current Assets23.8 B25.6 B21.7 B
Slightly volatile
Intangible Assets34.5 B60.1 B31.6 B
Slightly volatile
Property Plant Equipment3.4 B5.7 B3.4 B
Slightly volatile
Long Term Debt43 B60.3 B36.9 B
Slightly volatile
Short and Long Term Debt Total51.7 B67.1 B43.4 B
Slightly volatile
Non Currrent Assets Other9.6 B9.1 B3.3 B
Slightly volatile
Common Stock Total Equity15.4 M16.2 M710.2 M
Slightly volatile
Short Term Debt5.4 B6.8 B4.4 B
Slightly volatile
Common Stock15.4 M16.2 M710.2 M
Slightly volatile
Long Term Debt Total50.1 B68 B41.2 B
Slightly volatile
Capital Surpluse15.8 B22.1 B13.2 B
Slightly volatile
Long Term Investments475.7 M279 M497.8 M
Very volatile
Non Current Liabilities Other20.6 B27.6 B15.1 B
Slightly volatile
Short and Long Term Debt6.1 B6.8 B5.2 B
Slightly volatile
Net Invested Capital74.9 B70.5 B57.3 B
Slightly volatile
Capital Stock14.4 M16.2 M17.7 M
Slightly volatile

AbbVie Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization8.8 B8.4 B3.4 B
Slightly volatile
Selling General Administrative8.3 B14.8 B7.9 B
Slightly volatile
Total Revenue35.6 B56.3 B33.6 B
Slightly volatile
Gross Profit25.5 B39.4 B24.1 B
Slightly volatile
Other Operating Expenses25.5 B47.2 B24.1 B
Slightly volatile
Operating Income9.9 B9.1 B9.3 B
Slightly volatile
EBIT10.4 B6.5 B9.8 B
Slightly volatile
Research Development13.4 B12.8 B6.2 B
Slightly volatile
EBITDA13.7 B14.9 B12.9 B
Slightly volatile
Cost Of Revenue10.1 B16.9 B9.5 B
Slightly volatile
Total Operating Expenses15.2 B30.3 B14.4 B
Slightly volatile
Income Before Tax7.1 B3.7 B6.6 B
Slightly volatile
Net Income6.2 B4.3 B5.8 B
Slightly volatile
Net Income Applicable To Common Shares14.3 B13.6 B7.3 B
Slightly volatile
Net Income From Continuing Ops6.7 B4.3 B5.8 B
Slightly volatile
Non Recurring553.6 M801.5 M506.2 M
Slightly volatile
Interest Income349 M648 M494.8 M
Slightly volatile
Reconciled Depreciation6.3 B8.4 B3.9 B
Slightly volatile
Selling And Marketing Expenses2 B2.5 B1.5 B
Slightly volatile

AbbVie Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation464.2 M911 M440.6 M
Slightly volatile
Free Cash Flow12.6 B18.8 B11.9 B
Slightly volatile
Begin Period Cash Flow9.2 B12.8 B9 B
Slightly volatile
Depreciation8.8 B8.4 B3.8 B
Slightly volatile
Capital Expenditures640.3 M974 M594.1 M
Slightly volatile
Total Cash From Operating Activities13.1 B18.8 B12.4 B
Slightly volatile
Net Income6.2 B4.3 B5.8 B
Slightly volatile
End Period Cash Flow9.6 B5.5 B9.3 B
Slightly volatile
Dividends Paid7 B11 B5.7 B
Slightly volatile
Change To Netincome3.4 B3 B2.6 B
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.465.56834.3086
Slightly volatile
Dividend Yield0.02880.03510.0345
Slightly volatile
Days Sales Outstanding79.6270.746572.8356
Slightly volatile
Free Cash Flow Yield0.08790.060.0804
Very volatile
Operating Cash Flow Per Share5.7210.65347.3189
Slightly volatile
Stock Based Compensation To Revenue0.010.01620.0124
Slightly volatile
Capex To Depreciation0.09760.10.3097
Slightly volatile
EV To Sales4.116.66225.0747
Slightly volatile
Free Cash Flow Per Share5.4710.65347.0024
Slightly volatile
ROIC0.170.10210.1514
Slightly volatile
Inventory Turnover3.554.04314.383
Very volatile
Net Income Per Share2.742.42343.4444
Slightly volatile
Days Of Inventory On Hand93.3490.278385.3816
Very volatile
Payables Turnover6.695.73996.1191
Slightly volatile
Sales General And Administrative To Revenue0.280.230.2484
Slightly volatile
Research And Ddevelopement To Revenue0.140.22710.1678
Very volatile
Capex To Revenue0.0220.01650.0194
Slightly volatile
Cash Per Share4.833.14695.9674
Pretty Stable
POCF Ratio10.3116.680112.8213
Very volatile
Interest Coverage3.093.253918.1163
Slightly volatile
Payout Ratio2.712.57711.1612
Slightly volatile
Capex To Operating Cash Flow0.06830.03910.0593
Slightly volatile
PFCF Ratio15.2516.680114.0295
Very volatile
Days Payables Outstanding55.5663.5968.5789
Very volatile
Income Quality4.614.38782.3651
Slightly volatile
EV To Operating Cash Flow12.2519.956715.1161
Very volatile
PE Ratio76.9973.325432.1759
Slightly volatile
Return On Tangible Assets0.10.10660.2146
Slightly volatile
EV To Free Cash Flow13.1419.956716.221
Very volatile
Earnings Yield0.0130.01360.0446
Slightly volatile
Intangibles To Total Assets0.440.7030.5451
Slightly volatile
Current Ratio0.630.66021.4409
Slightly volatile
Receivables Turnover4.15.15935.0518
Pretty Stable
Graham Number14.9310.134418.858
Pretty Stable
Capex Per Share0.270.40.3427
Slightly volatile
Revenue Per Share33.5131.912620.9379
Slightly volatile
Interest Debt Per Share21.6639.627125.0502
Slightly volatile
Debt To Assets0.420.49680.4783
Slightly volatile
Enterprise Value Over EBITDA26.4325.171414.1918
Slightly volatile
Short Term Coverage Ratios2.632.76453.0649
Slightly volatile
Price Earnings Ratio76.9973.325432.1759
Slightly volatile
Operating Cycle173161158
Pretty Stable
Days Of Payables Outstanding55.5663.5968.5789
Very volatile
Dividend Payout Ratio2.712.57711.1612
Slightly volatile
Price To Operating Cash Flows Ratio10.3116.680112.8213
Very volatile
Price To Free Cash Flows Ratio15.2516.680114.0295
Very volatile
Pretax Profit Margin0.06270.0660.213
Slightly volatile
Ebt Per Ebit0.390.40670.7358
Slightly volatile
Operating Profit Margin0.320.16220.2875
Pretty Stable
Long Term Debt To Capitalization0.670.94780.7762
Slightly volatile
Total Debt To Capitalization0.680.95280.7829
Slightly volatile
Return On Capital Employed0.090.09480.1822
Slightly volatile
Ebit Per Revenue0.320.16220.2875
Pretty Stable
Quick Ratio0.520.55231.3122
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.621.70584.9263
Slightly volatile
Net Income Per E B T0.721.15120.8863
Pretty Stable
Cash Ratio0.140.14260.5841
Pretty Stable
Cash Conversion Cycle96.5797.434988.3365
Slightly volatile
Operating Cash Flow Sales Ratio0.280.33380.3508
Pretty Stable
Days Of Inventory Outstanding93.3490.278385.3816
Very volatile
Days Of Sales Outstanding79.6270.746572.8356
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.750.870.9237
Pretty Stable
Cash Flow Coverage Ratios0.270.280116.526
Slightly volatile
Fixed Asset Turnover7.6710.97279.4746
Slightly volatile
Capital Expenditure Coverage Ratio15.6126.4520.2224
Slightly volatile
Price Cash Flow Ratio10.3116.680112.8213
Very volatile
Enterprise Value Multiple26.4325.171414.1918
Slightly volatile
Debt Ratio0.420.49680.4783
Slightly volatile
Cash Flow To Debt Ratio0.270.280116.526
Slightly volatile
Price Sales Ratio3.465.56834.3086
Slightly volatile
Return On Assets0.03010.03170.0946
Slightly volatile
Asset Turnover0.570.41680.5201
Slightly volatile
Net Profit Margin0.07210.07590.1826
Slightly volatile
Gross Profit Margin0.80.69990.7364
Slightly volatile

AbbVie Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap296.4 B282.3 B182.1 B
Slightly volatile
Enterprise Value175.6 B337.8 B302 B
Slightly volatile

AbbVie Fundamental Market Drivers

Forward Price Earnings17.4825
Cash And Short Term Investments5.6 B

AbbVie Upcoming Events

2nd of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
2nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About AbbVie Financial Statements

AbbVie investors use historical fundamental indicators, such as AbbVie's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-3.3 B-3.5 B
Total Revenue56.3 B35.6 B
Cost Of Revenue16.9 B10.1 B
Stock Based Compensation To Revenue 0.02  0.01 
Sales General And Administrative To Revenue 0.23  0.28 
Research And Ddevelopement To Revenue 0.23  0.14 
Capex To Revenue 0.02  0.02 
Revenue Per Share 31.91  33.51 
Ebit Per Revenue 0.16  0.32 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY